Race and Alopecia Areata Amongst US Women

December 2017 in “ Journal of Investigative Dermatology Symposium Proceedings ”

Jordan M. Thompson, Min Kyung Park, Abrar A. Qureshi, Eunyoung Cho

alopecia areata AA Nurses' Health Study NHS Nurses' Health Study II NHSII racial disparities incidence multivariate-adjusted odds ratio

TLDR Black and Hispanic women are more likely to have alopecia areata than white women.

The study investigated racial disparities in alopecia areata (AA) among US women using data from the Nurses’ Health Study (NHS) and Nurses’ Health Study II (NHSII). Among 63,960 women in NHS and 88,368 in NHSII, 418 and 738 cases of AA were identified, respectively. The odds of AA were significantly higher in black women compared to white women, with odds ratios (ORs) of 2.72 in NHS and 5.48 in NHSII. Hispanic women in NHSII also had higher odds of AA compared to non-Hispanic white women (OR: 1.94). The study concluded that black and Hispanic women had increased odds of AA compared to white women, suggesting a need for further research to explore the underlying mechanisms of this racial disparity.

View this study on jidsponline.org →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

research Estimated Serum Vitamin D Status, Vitamin D Intake, and Risk of Incident Alopecia Areata Among US Women

23 citations, September 2016 in “Archives of Dermatological Research”

Vitamin D levels do not affect the risk of developing alopecia areata.

research Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata

222 citations, September 2016 in “JCI insight”

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

research Epidemiology and Burden of Alopecia Areata: A Systematic Review

144 citations, July 2015 in “Clinical, Cosmetic and Investigational Dermatology”

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

research Hepatitis C Treatment and Alopecia Totalis

8 citations, December 2013 in “Journal of Investigative Dermatology Symposium Proceedings”

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Prevalence and Etiology of Central Centrifugal Cicatricial Alopecia

Related Research

1 / 1 results

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child

April 2019 in “International journal of research in dermatology”

A child with rough nails also had hair loss and allergies.

Race and Alopecia Areata Amongst US Women

Research cited in this study

research Estimated Serum Vitamin D Status, Vitamin D Intake, and Risk of Incident Alopecia Areata Among US Women

research Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata

research Epidemiology and Burden of Alopecia Areata: A Systematic Review

research Hepatitis C Treatment and Alopecia Totalis

research Prevalence and Etiology of Central Centrifugal Cicatricial Alopecia

research Type 1 Interferon Signature in the Scalp Lesions of Alopecia Areata

research Alopecia in the United States: Outpatient Utilization and Common Prescribing Patterns

Related Community Posts Join

community How does dutasteride regrowth work?

community Why is no one pointing out dandruff as the number 1 evidence/symptom of MPB?

community If follicles became miniaturized and haven’t grown in 3 years, are they dead ?

community May have been mis-diagnosed for 10 years, self-investigation into AGA + AA Incognita (Defused Shedding)

community Nearly 40% of Adults with Alopecia Areata Taking OLUMIANT® 4-mg Saw at Least 80% Scalp Hair Coverage at 52 Weeks

community Anyone else taking Litfulo (ritlecitinib) to treat their alopecia?

Related Research

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child